Cargando…
Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study
BACKGROUND: Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral agent for patients infected with HIV-1 strains that do not harbor resistance mutations. Presence of tablet remnants of NVP XR in stools was reported in 1.19% and 3.05% of subjects in two clinical tr...
Autores principales: | Lee, Yi-Chieh, Lin, Shu-Wen, Chen, Mao-Yuan, Chang, Sui-Yuan, Kuo, Ching-Hua, Sheng, Wang-Huei, Hsieh, Szu-Min, Sun, Hsin-Yun, Chang, Hsi-Yen, Wu, Mon-Ro, Liu, Wen-Chun, Wu, Pei-Ying, Yang, Shang-Ping, Zhang, Jun-Yu, Su, Yi-Ching, Luo, Yi-Zhen, Hung, Chien-Ching, Chang, Shan-Chwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605833/ https://www.ncbi.nlm.nih.gov/pubmed/26465325 http://dx.doi.org/10.1371/journal.pone.0140574 |
Ejemplares similares
-
Impact of first-line protease inhibitors on predicted resistance to tipranavir in HIV-1-infected patients with virological failure
por: Hsieh, Szu-Min, et al.
Publicado: (2009) -
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection
por: Huang, Yu-Shan, et al.
Publicado: (2016) -
Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan
por: Chang, Sui-Yuan, et al.
Publicado: (2016) -
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
por: Huang, Sung-Hsi, et al.
Publicado: (2017) -
A cross-sectional seroprevalence for COVID-19 among healthcare workers in a tertially care hospital in Taiwan
por: Pan, Sung-Ching, et al.
Publicado: (2021)